NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. ERBITUX® cetuximab (rmc) CONSUMER MEDICINE INFORMATION What is in this leaflet This leaflet answers some common questions about ERBITUX. It does not contain all the available information….
Read More
Research reveals compromised transfer of SARS-CoV-2-specific antibodies through placenta
Recent analyses indicate that pregnant women and newborns may face elevated risks of developing more severe cases of COVID-19 following SARS-CoV-2 infection. New research led by investigators at Massachusetts General Hospital (MGH) and published in Cell reveals lower than expected…
Read More
Researchers testing children across British Columbia for COVID-19 antibodies
As COVID-19 cases continue to rise in British Columbia, a critical question remains on the role babies, children, teens and young adults play in transmission of the novel coronavirus. Dr. Manish Sadarangani, associate professor in the UBC department of pediatrics…
Read More
Children produce different antibodies in response to SARS-CoV-2
Children and adults produce different types and amounts of antibodies in response to infection with the new coronavirus, SARS-CoV-2, a new study from researchers at Columbia University Vagelos College of Physicians and Surgeons has found. The differences in antibodies suggest…
Read More
Scientists use holographic imaging to detect viruses and antibodies
A team of New York University scientists has developed a method using holographic imaging to detect both viruses and antibodies. The breakthrough has the potential to aid in medical diagnoses and, specifically, those related to the COVID-19 pandemic. “Our approach…
Read More
Researchers develop system for using everyday glucose monitors to detect COVID-19 antibodies
A trio of Johns Hopkins scientists—a pharmacologist, a biomedical engineer, and a biophysicist—are pooling their knowledge to design a device that can detect whether a person has antibodies linked to SARS-CoV-2, the virus that causes COVID-19. Antibodies are tiny proteins…
Read More
What we know about COVID-19 antibodies is changing. Here’s what’s new.
So much has changed since the first cases of the coronavirus emerged in the United States earlier this year, with masks and social distancing now becoming the norm of everyday life (or they should be, anyway). But perhaps the most fluid…
Read More
NIH trial to test antibodies and other therapeutics for mild, moderate COVID-19
A Phase 2 clinical trial will evaluate the safety and efficacy of potential new therapeutics for COVID-19, including an investigational therapeutic based on synthetic monoclonal antibodies (mAbs) to treat the disease. Researchers sponsored by the National Institute of Allergy and…
Read More
Coronavirus to SARS-CoV-2 infection, but not immunity? – Naturopathy Naturopathy Specialist Portal
Corona-infection: do Not automatically immune? According to the Federal centre for health education (BZgA), studies have shown that people develop after arrested by the SARS-CoV-2-infection-specific antibodies. “It is unclear, however, how robust and durable this immune status is established, and…
Read More
Coronavirus: Heinsberg-study – two million Infected in Germany? – Naturopathy Naturopathy Specialist Portal
Heinsberg-study: some 20 percent of the Corona Infected show no symptoms According to official data, over 160,000 people in Germany have so far with the novel Coronavirus SARS-CoV-2 plugged in. However, according to a study, the number of Infected could…
Read More